cognitive cybersecurity intelligence

News and Analysis

Search

New patent expiration for Aveo Pharms drug FOTIVDA

DrugPatentWatch reveals that Aveo Pharms’ FOTIVDA, or tivozanib hydrochloride, is protected by three patents with 52 patent family members in 26 countries. The drug is available from one supplier.

Source: www.drugpatentwatch.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts